EX-99.1 2 segrepsum.htm SEGMENT REPORTING SUMMARY Segment Reporting Summary
 
inVentiv Health Inc.
Quarterly Segment Reporting Summary
Q1 2006 - Q2 2007
(unaudited)
 

(in millions)
            
             
2006 Q1
inVentiv
inVentiv
inVentiv
inVentiv
   
 
Clinical
Commercial
Communications
Patient Outcomes
Corporate
Total
             
Revenue
$ 32.5
$ 86.2
$ 45.7
$ 9.3
$ -
$ 173.7
             
Adjusted Operating Income *
$ 1.6
$ 13.1
$ 7.6
$ 0.5
$ (2.3)
$ 20.5
Less: Stock Compensation Expense
0.3
0.9
0.1
0.1
0.2
1.6
Reported Operating Income
$ 1.3
$ 12.2
$ 7.5
$ 0.4
$ (2.5)
$ 18.9
             
             
2006 Q2
inVentiv
inVentiv
inVentiv
inVentiv
   
 
Clinical
Commercial
Communications
Patient Outcomes
Corporate
Total
             
Revenue
$ 38.4
$ 77.1
$ 50.8
$ 16.7
$ -
$ 183.0
             
Adjusted Operating Income *
$ 3.9
$ 11.7
$ 6.6
$ 2.1
$ (2.4)
$ 21.9
Less: Stock Compensation Expense
0.3
0.9
0.2
0.0
0.3
1.7
Reported Operating Income
$ 3.6
$ 10.8
$ 6.4
$ 2.1
$ (2.7)
$ 20.2
             
             
2006 Q3
inVentiv
inVentiv
inVentiv
inVentiv
   
 
Clinical
Commercial
Communications
Patient Outcomes
Corporate
Total
             
Revenue
$ 40.0
$ 88.1
$ 53.5
$ 16.2
$ -
$ 197.8
             
Adjusted Operating Income *
$ 4.2
$ 10.8
$ 8.9
$ 1.7
$ (2.9)
$ 22.7
Less: Stock Compensation Expense
0.3
0.9
0.2
0.2
0.6
2.2
Reported Operating Income
$ 3.9
$ 9.9
$ 8.7
$ 1.5
$ (3.5)
$ 20.5
             
             
2006 Q4
inVentiv
inVentiv
inVentiv
inVentiv
   
 
Clinical
Commercial
Communications
Patient Outcomes
Corporate
Total
             
Revenue
$ 39.0
$ 95.7
$ 57.4
$ 19.7
$ -
$ 211.8
             
Adjusted Operating Income *
$ 3.1
$ 13.5
$ 7.3
$ 3.4
$ (3.3)
$ 24.0
Less: Stock Compensation Expense
0.3
0.6
0.2
0.3
0.6
2.0
Adjusted Operating Income **
$ 2.8
$ 12.9
$ 7.1
$ 3.1
$ (3.9)
$ 22.0
             
Less: Acquisition-related incentive
-
-
3.5
-
-
3.5
Reported Operating Income
$ 2.8
$ 12.9
$ 3.6
$ 3.1
$ (3.9)
$ 18.5
             
             
2007 Q1
inVentiv
inVentiv
inVentiv
inVentiv
   
 
Clinical
Commercial
Communications
Patient Outcomes
Corporate
Total
             
Revenue
$ 41.4
$ 97.8
$ 61.4
$ 21.4
$ -
$ 222.0
             
Adjusted Operating Income *
$ 2.2
$ 10.0
$ 8.5
$ 3.6
$ (3.4)
$ 20.9
Less: Stock Compensation Expense
0.4
1.1
0.3
0.0
0.6
2.4
Reported Operating Income
$ 1.8
$ 8.9
$ 8.2
$ 3.6
$ (4.0)
$ 18.5
             
             
2007 Q2
inVentiv
inVentiv
inVentiv
inVentiv
   
 
Clinical
Commercial
Communications
Patient Outcomes
Corporate
Total
             
Revenue
$ 47.0
$ 97.8
$ 65.9
$ 21.7
$ -
$ 232.4
             
Adjusted Operating Income *
$ 3.2
$ 13.3
$ 9.1
$ 3.5
$ (3.3)
$ 25.8
Less: Stock Compensation Expense
0.4
1.1
0.3
0.1
0.6
2.5
Adjusted Operating Income **
$ 2.8
$ 12.2
$ 8.8
$ 3.4
$ (3.9)
$ 23.3
             
Less: Receivable reserve
-
8.2
-
-
-
8.2
Reported Operating Income
$ 2.8
$ 4.0
$ 8.8
$ 3.4
$ (3.9)
$ 15.1
             
             
* Excludes stock compensation expense, acquisition-related incentive and receivable reserve, where applicable.  (See Form 8-K, Item 7.01 for further details) 
** Excludes acquisition-related incentive and receivable reserve as disclosed above for 2006 Q4 and 2007 Q2, respectively. (See Form 8-K, Item 7.01 for further details)